SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that the Company will host an investor conference call on Wednesday, March 9, 2016 at 1:30pm PST (4:30pm EST).
In addition to discussion of second fiscal quarter 2016 results, the PURE management team will review the progress made to commercialize SDC as a food safety solution.
